Products

Oracle BetAI

AI-native

Two Markets. One AI Engine.

oraclebetai.qzz.io Entertainment & Media / Betting & Gambling

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Freemium model, plan pricing not identified yet
Launched
7mo ago
2026-04-24 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Advanced AI analyses live sports data and crypto markets

    Apr 24 · 7mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-05-04

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free Tier
$0
1 analysis per day · Sports AI access · Crypto AI access · Live data included
Premium
One-time
Unlimited analyses · All sports & leagues · All betting markets · Priority AI model · Lifetime access

Trial: None · Observed 2026-11-10 · Source page

Pages & changes

Tracked since 2026-04-24

Key pages

Weekly snapshots
Home
oraclebetai.qzz.io/ Snapshot 2026-11-10

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does Oracle BetAI cost?
Free Tier: $0; Premium: One-time. Observed 2026-11-10. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Oracle BetAI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Oracle BetAI and what platforms does it support?
Oracle BetAI is catalogued under Betting & Gambling: Two Markets. One AI Engine.. Supported platforms: Web.

Related products in this category

Entertainment & Media / Betting & Gambling

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.